UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review

Sagar, Rachel L; Walther-Jallow, Lilian; Götherström, Cecilia; Westgren, Magnus; David, Anna L; (2023) Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review. Prenatal Diagnosis 10.1002/pd.6459. (In press). Green open access

[thumbnail of Maternal and fetal safety outcomes after in utero stem cell injection.pdf]
Preview
PDF
Maternal and fetal safety outcomes after in utero stem cell injection.pdf - Published Version

Download (456kB) | Preview

Abstract

Objective: To investigate the maternal and fetal safety of In utero stem cell transplantation (IUSCT). Methods: Medline®, Embase and Cochrane library (1967−2023) search for publications reporting IUSCT in humans. Two reviewers independently screened abstracts and full-text papers. Results: Sixty six transplantation procedures in 52 fetuses were performed for haemoglobinopathies (n = 14), red cell/bleeding disorders (n = 4), immunodeficiencies (n = 15), storage disorders (n = 7), osteogenesis imperfecta (n = 2) and healthy fetuses (n = 10). The average gestational age was 18.9 weeks; of procedures reporting the injection route, cells were delivered by intraperitoneal (n = 37), intravenous (n = 19), or intracardiac (n = 4) injection or a combination (n = 3); most fetuses received one injection (n = 41). Haematopoietic (n = 40) or mesenchymal (n = 12) stem cells were delivered. The cell dose was inconsistently reported (range 1.8−3.3 × 109 cells total (n = 27); 2.7−5.0 × 109/kg estimated fetal weight (n = 17)). The acute fetal procedural complication rate was 4.5% (3/66); the acute fetal mortality rate was 3.0% (2/66). Neonatal survival was 69.2% (36/52). Immediate maternal and pregnancy outcomes were reported in only 30.8% (16/52) and 44.2% (23/52) of cases respectively. Four fetal/pregnancy outcomes would also classify as ≥ Grade 2 maternal adverse events. Conclusions: Short-, medium-, and long-term maternal and fetal adverse events should be reported in all IUSCT studies.

Type: Article
Title: Maternal and fetal safety outcomes after in utero stem cell injection: A systematic review
Location: England
Open access status: An open access version is available from UCL Discovery
DOI: 10.1002/pd.6459
Publisher version: https://doi.org/10.1002/pd.6459
Language: English
Additional information: © 2023 The Authors. Prenatal Diagnosis published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL EGA Institute for Womens Health > Maternal and Fetal Medicine
URI: https://discovery.ucl.ac.uk/id/eprint/10181856
Downloads since deposit
8Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item